Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 2,111 | 2,889 | 3,028 | 3,211 | 5,242 |
| Operating Income | -2,111 | -2,889 | -3,028 | -3,211 | -5,242 |
| Other Income | 0 | 6 | 38 | 67 | 92 |
| Pre-tax Income | -2,111 | -2,883 | -2,990 | -3,144 | -5,150 |
| Net Income Continuous | -2,111 | -2,883 | -2,990 | -3,144 | -5,150 |
| Minority Interests | -8 | -16 | -26 | -4 | -30 |
| Net Income | $-2,103 | $-2,867 | $-2,964 | $-3,140 | $-5,120 |
| EPS Basic Total Ops | -35.00 | -45.00 | -50.00 | -47.50 | -77.50 |
| EPS Basic Continuous Ops | -27.21 | -39.16 | -43.73 | -46.94 | -76.61 |
| EPS Diluted Total Ops | -35.00 | -45.00 | -50.00 | -47.50 | -77.50 |
| EPS Diluted Continuous Ops | -27.21 | -39.16 | -43.73 | -46.94 | -76.61 |
| EBITDA(a) | $-2,058 | $-2,831 | $-2,970 | $-3,153 | $-5,182 |